AU2003279461A8 - Disorders of lipid metabolism - Google Patents
Disorders of lipid metabolismInfo
- Publication number
- AU2003279461A8 AU2003279461A8 AU2003279461A AU2003279461A AU2003279461A8 AU 2003279461 A8 AU2003279461 A8 AU 2003279461A8 AU 2003279461 A AU2003279461 A AU 2003279461A AU 2003279461 A AU2003279461 A AU 2003279461A AU 2003279461 A8 AU2003279461 A8 AU 2003279461A8
- Authority
- AU
- Australia
- Prior art keywords
- disorders
- lipid metabolism
- metabolism
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000037356 lipid metabolism Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0226039A GB0226039D0 (en) | 2002-11-07 | 2002-11-07 | Conditions of lipid excess |
| GB0226039.6 | 2002-11-07 | ||
| GB0226152.7 | 2002-11-08 | ||
| GB0226152A GB0226152D0 (en) | 2002-11-08 | 2002-11-08 | Conditions of lipid excess |
| GB0305463A GB0305463D0 (en) | 2003-03-10 | 2003-03-10 | Disorders of lipid metabolism |
| GB0305463.2 | 2003-03-10 | ||
| GB0323689A GB0323689D0 (en) | 2003-10-09 | 2003-10-09 | Disorders of lipid metabolism |
| GB0323689.0 | 2003-10-09 | ||
| PCT/GB2003/004816 WO2004042064A2 (en) | 2002-11-07 | 2003-11-07 | Disorders of lipid metabolism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003279461A8 true AU2003279461A8 (en) | 2004-06-07 |
| AU2003279461A1 AU2003279461A1 (en) | 2004-06-07 |
Family
ID=32314923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003279461A Abandoned AU2003279461A1 (en) | 2002-11-07 | 2003-11-07 | Disorders of lipid metabolism |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003279461A1 (en) |
| WO (1) | WO2004042064A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2018014366A (en) * | 2016-05-27 | 2019-04-11 | Synthex Inc | Protein interfaces. |
-
2003
- 2003-11-07 WO PCT/GB2003/004816 patent/WO2004042064A2/en not_active Ceased
- 2003-11-07 AU AU2003279461A patent/AU2003279461A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004042064A3 (en) | 2004-12-02 |
| AU2003279461A1 (en) | 2004-06-07 |
| WO2004042064A2 (en) | 2004-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165820A0 (en) | Diphenylazetidinone derivatives for treating disorders of the lipid metabolism | |
| AU2003205950A8 (en) | Placement of alternative advertisements | |
| IL163863A0 (en) | Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz | |
| AU2003298738A8 (en) | Liposomal formulations | |
| AU2003286728A8 (en) | Compounds for the treatment of metabolic disorders | |
| AU2003228648A8 (en) | Securitization of sales participation certificates | |
| AU2003232956A8 (en) | Purchase of services | |
| AU2003302320A8 (en) | Seterocyclic quinones as pharmaceutical agents | |
| AU2003279461A8 (en) | Disorders of lipid metabolism | |
| GB0323689D0 (en) | Disorders of lipid metabolism | |
| GB0305463D0 (en) | Disorders of lipid metabolism | |
| AU2003266714A8 (en) | Phospholipid derivative | |
| AU2003266210A8 (en) | Use of mas-compounds for treating diseases associated with lipid metabolism | |
| IL172377A0 (en) | 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders | |
| GB0226152D0 (en) | Conditions of lipid excess | |
| GB0226039D0 (en) | Conditions of lipid excess | |
| HK1075251A (en) | Diphenylazetidinone derivatives for treating disorders of the lipid metabolism | |
| AU2002361078A1 (en) | Markers for sugar/lipid metabolic disorders and utilization thereof | |
| GB0218936D0 (en) | Lipid metabolism enhancing drink | |
| TW534417U (en) | Structure improvement of advertisement framework | |
| EP1383380A4 (en) | Fizz1 for metabolism regulation | |
| GB0209859D0 (en) | Lipid compositions | |
| GB2380661B (en) | Confectionery support | |
| HU0200197V0 (en) | Advertising for stairs | |
| TW578557U (en) | Structure of wearable dribbler stand |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |